Abstract
SARS-CoV-2 infection and the resulting COVID-19 have afflicted millions of people in an ongoing worldwide pandemic. Safe and effective vaccination is available to protect not only the general population but also vulnerable subjects, such as patients with cancer. A large body of research concordantly demonstrates that currently approved SARS-CoV-2 vaccines are suitable for patients with cancer based on their mode of action, efficacy, and favorable safety profile reported in the general population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
